FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is using a prostaglandin compound for general formula (II) for making a pharmaceutical composition for treating inflammatory intestinal diseases, cancer, gastroesophageal reflux disease or Barrett's syndrome in a mammal subject (versions), related methods of treating (versions) and pharmaceutical compositions (versions). It has been shown that the compound of formula 
induces the conformational alteration in close contact which enables functional recovery of the mucosal barrier. What is shown as treating the injured mucosa with the compound: colon inflammation, colon cancer (prevented tumour growth).
EFFECT: preparing the compounds enabling the functional recovery of mucosal barrier.
25 cl, 6 dwg, 2 tbl
